药学学报, 2021, 56(10): 2761-2768
引用本文:
刘俊彤, 赖思含, 付东兴, 周柏松, 李平亚*, 刘金平. 抗心肌缺血天然药物研究进展[J]. 药学学报, 2021, 56(10): 2761-2768.
LIU Jun-tong, LAI Si-han, FU Dong-xing, ZHOU Bai-song, LI Ping-ya*, LIU Jin-ping. Research progress of natural medicine against myocardial ischemia[J]. Acta Pharmaceutica Sinica, 2021, 56(10): 2761-2768.

抗心肌缺血天然药物研究进展
刘俊彤, 赖思含, 付东兴, 周柏松, 李平亚*, 刘金平
吉林大学药学院, 吉林 长春 130021
摘要:
近年来对心肌缺血疾病的研究日益深入,与抗心肌缺血有关的药物也越来越多,其中,天然药物发挥了重要作用。为应对多种致病原因所致的心肌缺血疾病,对天然药物的研究也越发深入,目前以含有皂苷类、黄酮类、生物碱类等化合物的天然药物为主要研究对象,对抗心肌缺血天然药物的临床应用研究也取得了很大进展。本文对近十年国内外抗心肌缺血天然药物研究进展进行了综述。
关键词:    心肌缺血      天然药物      临床应用     
Research progress of natural medicine against myocardial ischemia
LIU Jun-tong, LAI Si-han, FU Dong-xing, ZHOU Bai-song, LI Ping-ya*, LIU Jin-ping
School of Pharmacy, Jilin University, Changchun 130021, China
Abstract:
In recent years, the research on myocardial ischemia disease is increasingly in-depth, and there are more and more drugs related to the anti-myocardial ischemia, among which natural medicines play an important role. In order to deal with myocardial ischemia diseases caused by a variety of pathogenic causes, the research on natural medicines is more and more deep. At present, natural medicines containing saponins, flavonoids, alkaloids and other compounds are the research objects. At the same time, great progress has been made in the research on the clinical application of natural drugs against myocardial ischemia. This article reviews the research progress of natural medicines against myocardial ischemia at home and abroad in the past ten years.
Key words:    myocardial ischemia    natural medicine    clinical application   
收稿日期: 2021-03-11
DOI: 10.16438/j.0513-4870.2021-0357
基金项目: 吉林省重大科技专项课题(20200504006YY).
通讯作者: 李平亚,Tel:86-431-85619803,E-mail:lipy@jlu.edu.cn
Email: lipy@jlu.edu.cn
相关功能
PDF(498KB) Free
打印本文
0
作者相关文章
刘俊彤  在本刊中的所有文章
赖思含  在本刊中的所有文章
付东兴  在本刊中的所有文章
周柏松  在本刊中的所有文章
李平亚*  在本刊中的所有文章
刘金平  在本刊中的所有文章

参考文献:
[1] Joseph P, Leong D, Mckee M, et al. Reducing the global burden of cardiovascular disease, Part 1:the epidemiology and risk factors[J]. Circ Res, 2017, 121:677-694.
[2] Dong ZX, Feng JJ, Lin LK. Study on the application of traditional Chinese medicine injections in cardiovascular diseases[J]. China Res Hosp (中国研究型医院), 2019, 6:25-32.
[3] Pagliaro BR, Cannata F, Stefanini GG, et al. Myocardial ischemia and coronary disease in heart failure[J]. Heart Fail Rev, 2020, 25:53-65.
[4] Yao L, Chen HG, Wu QH, et al. Hydrogen-rich saline alleviates inflammation and apoptosis in myocardial I/R injury via PINK-mediated autophagy[J]. Int J Mol Med, 2019, 44:1048-1062.
[5] Lebaron TW, Kura B, Kalocayova B, et al. A new approach for the prevention and treatment of cardiovascular disorders. molecular hydrogen significantly reduces the effects of oxidative stress[J]. Molecules, 2019, 24:1420-3049.
[6] Gray CB, Suetomi T, Xiang S, et al. CaMKIIdelta subtypes differentially regulate infarct formation following ex vivo myocardial ischemia/reperfusion through NF-kappaB and TNF-alpha[J]. J Mol Cell Cardiol, 2017, 103:48-55.
[7] Shintani-ishida K, Inui M, Yoshida K. Ischemia-reperfusion induces myocardial infarction through mitochondrial Ca2+ overload[J]. J Mol Cell Cardiol, 2012, 53:233-239.
[8] Zheng XJ, Xu HB. Research progress on the mechanism of anti-myocardial ischemia-reperfusion injury of saponins from traditional Chinese medicine[J]. J Emerg Tradit Chin Med, 2012, 21:443-445.
[9] Aravinthan A, Kim JH, Antonisamy P, et al. Ginseng total saponin attenuates myocardial injury via anti-oxidative and anti-inflammatory properties[J]. J Ginseng Res, 2015, 39:206-212.
[10] Guo M, Liu J, Guo F, et al. Panax quinquefolium saponins attenuate myocardial dysfunction induced by chronic ischemia[J]. Cell Physiol Biochem, 2018, 49:1277-1288.
[11] Wu Y, Lu X, Xiang FL, et al. North American ginseng protects the heart from ischemia and reperfusion injury via upregulation of endothelial nitric oxide synthase[J]. Pharmacol Res, 2011, 64:195-202.
[12] Yin H, Liu Z, Li F, et al. Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction[J]. J Mol Med (Berl), 2011, 89:363-375.
[13] Shi Y, Han B, Yu X, et al. Ginsenoside Rb3 ameliorates myocardial ischemia-reperfusion injury in rats[J]. Pharm Biol, 2011, 49:900-906.
[14] Liu X, Jiang Y, Yu X, et al. Ginsenoside-Rb3 protects the myocardium from ischemia-reperfusion injury via the inhibition of apoptosis in rats[J]. Exp Ther Med, 2014, 8:1751-1756.
[15] Wang Z, Li M, Wu WK, et al. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction[J]. Cardiovasc Drugs Ther, 2008, 22:443-452.
[16] Yamabe N, Song KI, Lee W, et al. Chemical and free radical-scavenging activity changes of ginsenoside Re by maillard reaction and its possible use as a renoprotective agent[J]. J Ginseng Res, 2012, 36:256-262.
[17] Lim KH, Kang CW, Choi JY, et al. Korean red ginseng induced cardioprotection against myocardial ischemia in guinea pig[J]. Korean J Physiol Pharmacol, 2013, 17:283-289.
[18] Lim KH, Cho JY, Kim B, et al. Red ginseng (Panax ginseng) decreases isoproterenol-induced cardiac injury via antioxidant properties in porcine[J]. J Med Food, 2014, 17:111-118.
[19] Gao WM, Zhou Y, Ren XY. Protective effect of Panax notoginseng stem and leaf saponins on isoproterenol-induced acute myocardial ischemia in rats[J]. Drugs Clin, 2019, 34:1615-1619.
[20] Zhou W, Liu ZG. The protective effect of notoginsenoside R1 pretreatment on myocardial ischemia-reperfusion injury in rats and related mechanisms[J]. Chin J Clin Pharmacol (中国临床药理学杂志), 2019, 35:2589-2592.
[21] Yu Y, Sun G, Luo Y, et al. Cardioprotective effects of notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress-and endoplasmic reticulum stress-related signaling pathways[J]. Sci Rep, 2016, 6:21730.
[22] Chen SX, Wen PJ, Wu YH, et al. Study on the relationship between anti-cardiomyocyte apoptosis effect of Panax notoginseng saponins and MIF[J]. Pharm Today, 2020, 30:243-245.
[23] Deng HY, Lai WG. Protective effect of notoginsenoside R1 on acute myocardial ischemia rat model[J]. Chin J Exp Tradit Med Form (中国实验方剂学杂志), 2013, 19:265-268.
[24] Zhang Y, Dai SY, Xu B, et al. Progress in pharmacological research of Panax notoginseng saponins against myocardial ischemia-reperfusion injury[J]. Jiangsu J Tradit Chin Med (江苏中医药), 2017, 49:82-85.
[25] Pan C, Huo Y, An X, et al. Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation[J]. Vascul Pharmacol, 2012, 56:150-158.
[26] Zhu D, Wu L, Li CR, et al. Ginsenoside Rg1 protects rat cardiomyocyte from hypoxia/reoxygenation oxidative injury via antioxidant and intracellular calcium homeostasis[J]. J Cell Biochem, 2009, 108:117-124.
[27] Ma XL, Wang GM. The protective effect of pretreatment with astragaloside IV on myocardial ischemia-reperfusion injury in rats[J]. Chin J Gerontol (中国老年学杂志), 2015, 35:4795-4796.
[28] Ge HJ, Guo YL, Zhou N, et al. Astragaloside IV mediates SERCA2a pathway to improve myocardial ischemia-reperfusion injury in rats[J]. Prog Anatom Sci (解剖科学进展), 2020, 26:697-700+5.
[29] Gong AD, Sun JH. A preliminary study on the effect of astragaloside IV on Ca2+ concentration in a rat model of myocardial ischemia and arrhythmia[J]. Asia-Pac Tradit Med (亚太传统医药), 2013, 9:11-12.
[30] He YG, Li WF, Yi HL, et al. Study on the mitochondrial mechanism of astragaloside IV inhibiting GSK-3β activity-mediated myocardial ischemia/reperfusion injury in rats[J]. Chin Pharmacol Bull (中国药理学通报), 2014, 30:402-406.
[31] Guan FY, Li H, Yang SJ. The protective effect and mechanism of astragaloside IV pretreatment on myocardial ischemia-reperfusion injury in rats[J]. Chin Tradit Herb Drugs (中草药), 2010, 41:1146-1150.
[32] Chen QH, Li Q, Yang WJ, et al. Research progress on the related mechanism of flavonoids against myocardial ischemia reperfusion injury[J]. Chin J Clin Pharmacol (中国临床药理学杂志), 2013, 29:958-960.
[33] Fan YF, Wang YH, Zhang JH, et al. The protective effect and mechanism of total flavonoids of rhododendron on myocardial ischemia-reperfusion injury in rats in vivo[J]. Chin Tradit Herb Med(中草药), 2008, 4:240-244.
[34] Li GD, Xue T, Huang XF. The cardioprotective effect of hyperoside on myocardial ischemia-reperfusion injury in rats[J]. Chin J Clin Pharmacol(中国临床药理学杂志), 2020, 36:3721-3724.
[35] Han J, Xuan JL, Hu HR, et al. The relationship between the effect of hyperoside pretreatment on reducing myocardial ischemia-reperfusion injury in rats and the PI3K/Akt signaling pathway[J]. China J Chin Mater Med (中国中药杂志), 2015, 40:118-123.
[36] Liu H, Zhang W, Lu SP. Antioxidant effect of quercetin on myocardial injury in rats[J]. Shaanxi Med J (陕西医学杂志), 2017, 46:995-996.
[37] Li DM, Zhang YY, Xu L, et al. The protective effect and mechanism of quercetin on myocardial ischemia-reperfusion injury[J]. Pract Pharm Clin Remed (实用药物与临床), 2016, 19:410-413.
[38] Zhang XM, Qian XF. The protective effect of quercetin on myocardial ischemia-reperfusion injury in rats[J]. China Pharm (中国药师), 2015, 18:1895-1898.
[39] Xuan JL, Wu SX. The effect of puerarin on myocardial ischemia-reperfusion injury in rats and its mechanism[J]. J Taishan Med Coll (泰山医学院学报), 2017, 38:248-250.
[40] Li J, Shi B, Huang KX, et al. Effects of puerarin on the expression levels of Bcl-2, Bax and Caspase-3 in myocardial tissue of myocardial ischemia-reperfusion rats[J]. Chin J Lab Diagn (中国实验诊断学), 2013, 17:631-633.
[41] Yao SQ, Cui CL. The effect of puerarin on Cx43 in myocardial ischemia-reperfusion injury in rats[J]. J Baotou Med Coll (包头医学院学报), 2016, 32:37-39.
[42] Liu GL, Yang W, Wang YX, et al. The effect and mechanism of puerarin on arrhythmia induced by myocardial ischemia-reperfusion in rats[J]. Gen Appl Biol, 2020, 39:3350-3354.
[43] Wang ZK, Li JH, Li W, et al. The protective effect and mechanism of puerarin on myocardial ischemia-reperfusion injury in rats[J]. Clin J Med Off (临床军医杂志), 2020, 48:528-531, 535.
[44] Peng J, Xu WJ, He BX, et al. Effects of baicalein on rat myocardial ischemia and neonatal cardiomyocyte injury[J]. Chin J Nat Med, 2011, 9:132-140.
[45] Wang JW, Yi DL, Wang T, et al. The protective effect of baicalein on myocardial ischemia-reperfusion injury in rats and its effect on the Janus kinase signal transduction and transcriptional activation molecular signaling pathway[J]. Chin J Gerontol (中国老年学杂志), 2020, 40:2410-2414.
[46] Tan S, Zhou S, Luo Y. Baicalein pretreatment confers cardioprotection against acute myocardial infarction by activating the endothelial nitric oxide synthase signaling pathway and inhibiting oxidative stress[J]. Mol Med Rep, 2014, 9:2429-2434.
[47] Liang ZQ, Deng J, Yuan Y, et al. Effects of the total flavonoids of flavonoids on the levels of mTOR signaling pathway and related autophagy proteins in rats with myocardial ischemia-reperfusion injury[J]. J Shihezi Univ (Nat Sci) (石河子大学学报自然科学版), 2020, 38:513-518.
[48] Hong Y, Yuan Y, Cao WJ, et al. Study on the autophagy effect of the total flavonoids of sweet green orchid on the autophagy induced by myocardial ischemia-reperfusion injury in rats[J]. Chin Pharm J (中国药学杂志), 2016, 51:890-895.
[49] Yao JM, Cao WJ, Yuan Y, et al. The protective effect of the total flavonoids of sweet green orchid on myocardial ischemia-reperfusion injury mitochondria[J]. J Shihezi Univ (Nat Sci) (石河子大学学报自然科学版), 2015, 33:599-603.
[50] Fan XM, Cao WJ, Xing JG, et al. Study on the protective effect of the total flavonoids of fragrans on myocardial ischemia-reperfusion injury in rats[J]. Chin Tradit Pat Med (中成药), 2013, 35:1625-1629.
[51] Ci HD, Yang X, Zhu XX, et al. Protective effects of total flavonoids of hickory leaves on mice against myocardial ischemia and hypoxia injury of myocardial cells[J]. J Yunnan Univ Tradit Chin Med (云南中医药大学学报), 2015, 38:1-5.
[52] Chen C, Xu DP, Jin M, et al. Extraction and separation of serotonin from walnut and its anti-myocardial ischemia activity[J]. Food Machinery, 2019, 35:167-171.
[53] Xu XN, Niu ZR, Wang SB, et al. The effect and mechanism of total flavonoids of bugloss on myocardial ischemia-reperfusion injury in rats[J]. Acta Pharm Sin (药学学报), 2014, 49:875-881.
[54] Zhao CG, Qin SZ, Zhang Y, et al. Experimental study on anti-myocardial ischemia effects of ghost arrow feathers[J]. West J Tradit Chin Med (西部中医药), 2015, 28:19-21.
[55] Wang F, Han JC, Li DF, et al. Anti-myocardial ischemia-reperfusion injury and its mechanism of total flavonoids of Apocynum venetum[J]. Pharm Care Res, 2018, 18:16-20.
[56] Wang YX, Li F, Wang J, et al. A study on the mechanism of anti-myocardial ischemia of Abelmoschus manihot based on network pharmacology[J]. China Pharm (中国药师), 2020, 23:1700-1709.
[57] Li HF, Pang KJ, Li L, et al. Study on the mechanism of anti-myocardial ischemia-reperfusion injury of flavonoids from Sorbus tianshanensis[J]. Chin Tradit Herb Drugs (中草药), 2020, 51:5243-5253.
[58] Zhu JX, Rao LL. Effects of Chuanxiong on myocardial ischemia-reperfusion injury in rats[J]. China Mod Med (中国当代医药), 2016, 23:109-111.
[59] Rao LL. The effect of Chuanxiong on NF-κB in rats with myocardial ischemia reperfusion[J]. Guangdong Trace Elements Sci (广东微量元素科学), 2016, 23:10-13.
[60] Chen DS, Guo LH. Effects of Ligusticum chuanxiong extract on myocardial ischemia-reperfusion injury in rats[J]. Mod J Integr Tradit Chin West Med (现代中西医结合杂志), 2010, 19:3427-3429.
[61] Wang G, Liu Y, Hou XF, et al. Ligusticum chuanxiong extract protects against oxidative stress injury in rats with myocardial ischemia by activating the Nrf2 pathway[J]. China J Chin Mater Med (中国中药杂志), 2017, 42:4834-4840.
[62] Gao ZQ, Xie H, Chen L. Study on the protective effect of aconitine alkaloid aconitine on myocardial ischemia/reperfusion injury in rats[J]. Jiangsu J Tradit Chin Med (江苏中医药), 2015, 47:79-81.
[63] Yu YY, Shao J, Chen F, et al. Study on the oxidized isoaporphine-type alkaloids and their anti-myocardial ischemic activity in the roots of North Bean[J]. J Logistics Univ PAP (Med Sci) (武警后勤学院学报医学版), 2019, 28:1-6.
[64] Tian B, Kang TJ, Jia JL, et al. Protective effect and mechanism of total alkaloids of Corydalis yanhusuo on acute myocardial ischemia in dogs[J]. Res Pract Mod Chin Med (现代中药研究与实践), 2020, 34:31-39.
[65] Xu DP, Hu CY, Mei JL, et al. Alkaloids in seabuckthorn seed meal and their anti-myocardial ischemic activity[J]. Nat Prod Res Devel (天然产物研究与开发), 2010, 22:937-939.
[66] Chen W, Gao FX, Guo LL, et al. Study on the mechanism of the protective effect of salvianolic acid on myocardial ischemia-reperfusion injury[J]. Chin J Exp Tradit Med Form (中国实验方剂学杂志), 2013, 19:242-245.
[67] Niu ZR, Xu XN, Chen YC, et al. Protective effect of salvianolic acid A on isoprenaline-induced myocardial ischemia in mice and its mechanism[J]. Chin Pharmacol Bull (中国药理学通报), 2015, 31:1667-1674.
[68] Chen Y, Li H, Zhang S, et al. Anti-myocardial ischemia effect and components of litchi pericarp extracts[J]. Phytother Res, 2017, 31:1384-1391.
[69] Liu YQ, Liu H, Han PL, et al. Ginkgolide protects rat myocardial injury caused by ischemia-reperfusion through anti-inflammatory and antioxidant effects[J]. Chin J Pharmacol Toxicol (中国药理学与毒理学杂志), 2019, 33:241-249.
[70] Wang Y, Gou DF. Efficacy and dose relationship of Suhexiang on myocardial ischemia model rats[J]. Acta Chin Med (中医学报), 2019, 34:2157-2163.
[71] Jiang WL, Zhang SM, Tang XX, et al. Protective roles of cornuside in acute myocardial ischemia and reperfusion injury in rats[J]. Phytomedicine, 2011, 18:266-271.
[72] Yu FH, Li HX, Su BJ, et al. Experimental study on the effects of allicin on arrhythmia and cardiac function after acute myocardial ischemia-reperfusion[J]. J Electrocardiol Circ, 2019, 38:471-476, 549.
[73] Han CY, Deng WJ, Li Z, et al. Screening the molecular mechanism of Gastrodia against myocardial ischemia based on network pharmacology[J]. World Latest Med Inf (世界最新医学信息文摘), 2019, 19:25-28.
[74] Wang XP, Wang PF, Bai JQ, et al. Investigating the effects and possible mechanisms of danshen-honghua herb pair on acute myocardial ischemia induced by isoproterenol in rats[J]. Biomed Pharmacother, 2019, 118:109268.
[75] Li YH, Wei Y, Cheng WH, et al. Protective effects of Panax notoginseng saponins and safflower extract on myocardial ischemia and reperfusion injury[J]. Mod Tradit Chin Med Mater Med-World Sci Technol (世界科学技术中医药现代化), 2019, 21:1346-1352.
[76] Chen HQ. Research progress on the cardiovascular protective effects of Panax notoginseng saponins, Ginkgo biloba extract and their combination[J]. J Ningde Norm Univ (Nat Sci) (宁德师范大学学报自然科学版), 2019, 31:286-291.
[77] Liang Q, Li WJ, Yang XL, et al. Research progress of compound Danshen dripping pills in improving myocardial ischemia-reperfusion injury[J]. Chin J Mod Drug Appl (中国现代药物应用), 2020, 14:236-238.
[78] Yang WG, Wan L. Clinical observation of compound Danshen dripping pills combined with vitamin B6 in the treatment of middle-aged and elderly myocardial ischemia[J]. Inner Mong J Tradit Chin Med (内蒙古中医药), 2014, 33:59.
[79] Wu YL, Li X. The effect of Naoxintong capsule combined with western medicine in the treatment of acute cerebral infarction with myocardial ischemia[J]. Cardiovasc Dis Electron J Int Tradit Chin West Med (中西医结合心血管病电子杂志), 2018, 6:162.
[80] Guo H, Ren JX, Hao TT, et al. Protective effects of Ginkgo biloba and honey ring oral solution on acute myocardial ischemia injury in rats[J]. Acta Pharm Sin (药学学报), 2017, 52:1865-1870.